Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04742608 · ClinicalTrials.gov registry record
Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
A clinical trial of Thyroid Gland Carcinoma and Thyroid Gland Nodule, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04742608 is a study of Thyroid Gland Carcinoma and Thyroid Gland Nodule that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 250 participants, below the 714-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04742608, a study of Thyroid Gland Carcinoma and Thyroid Gland Nodule, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Electronic Health Record Review
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-02-21 |
| Est. Completion | 2027-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04742608
The ClinicalTrials.gov registry entry for NCT04742608 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 714-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (65% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thyroid Gland Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT04742608 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04742608 about?
NCT04742608 is a clinical study titled "Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer". This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patie...
What is the current status of trial NCT04742608?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2020-02-21. Estimated completion is 2027-02-01.
What conditions does trial NCT04742608 study?
This clinical trial studies the following conditions: Thyroid Gland Carcinoma, Thyroid Gland Nodule.
What interventions are being tested in trial NCT04742608?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04742608?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04742608 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Gland Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
RECRUITING
-
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
RECRUITING · Phase 1
-
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.